Barinthus Biotherapeutics plc. — insider transactions

49 transactions on record · CIK 1828185

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
49
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
8
Bought, 3m
$0
Sold, 3m
$0
Median disclosure lag
0.0 d
trade date to filing date
Largest single trade, 24m
Director share, 12m
91.8%
of transactions where role is stated
Current run
49 sells
consecutive same-direction transactions
Net 3m flow
$0
purchases minus sales
Total on record
49

Transactions

49 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-09-092026-09-090DAWES KAREN ADirectorDisposition to issuer34,328$0.00filing
2026-09-092026-09-090DAWES KAREN ADirectorDisposition to issuer19,516$0.00filing
2026-09-092026-09-090Enright WilliamDirector, Chief Executive OfficerDisposition to issuer514,923filing
2026-09-092026-09-090Enright WilliamDirector, Chief Executive OfficerDisposition to issuer440,000$0.00filing
2026-09-092026-09-090DAWES KAREN ADirectorDisposition to issuer18,604$0.00filing
2026-09-092026-09-090DAWES KAREN ADirectorDisposition to issuer20,174$0.00filing
2026-09-092026-09-090Enright WilliamDirector, Chief Executive OfficerDisposition to issuer176,130$0.00filing
2026-09-092026-09-090Enright WilliamDirector, Chief Executive OfficerDisposition to issuer443,981$0.00filing
2026-09-092026-09-090Hammacher AlexDirectorDisposition to issuer34,328$0.00filing
2026-09-092026-09-090DAWES KAREN ADirectorDisposition to issuer1,700filing
2026-09-092026-09-090DAWES KAREN ADirectorDisposition to issuer19,197$0.00filing
2026-09-092026-09-090Enright WilliamDirector, Chief Executive OfficerDisposition to issuer728,454filing
2026-09-092026-09-090Enright WilliamDirector, Chief Executive OfficerDisposition to issuer359,605$0.00filing
2026-09-092026-09-090Enright WilliamDirector, Chief Executive OfficerDisposition to issuer600,000$0.00filing
2026-09-092026-09-090Hammacher AlexDirectorDisposition to issuer18,604$0.00filing
2026-09-092026-09-090Hammacher AlexDirectorDisposition to issuer20,174$0.00filing
2026-09-092026-09-090Hooftman LeonChief Medical OfficerDisposition to issuer195,166$0.00filing
2026-09-092026-09-090Morgon Pierre A.DirectorDisposition to issuer20,394$0.00filing
2026-09-092026-09-090Morgon Pierre A.DirectorDisposition to issuer19,197$0.00filing
2026-09-092026-09-090Phillips Anne M.DirectorDisposition to issuer3,000filing
2026-09-092026-09-090Hammacher AlexDirectorDisposition to issuer3,000filing
2026-09-092026-09-090Hammacher AlexDirectorDisposition to issuer19,197$0.00filing
2026-09-092026-09-090Hooftman LeonChief Medical OfficerGrant or award361,530filing
2026-09-092026-09-090Hooftman LeonChief Medical OfficerDisposition to issuer140,000$0.00filing
2026-09-092026-09-090Morgon Pierre A.DirectorDisposition to issuer34,328$0.00filing
2026-09-092026-09-090Morgon Pierre A.DirectorDisposition to issuer19,516$0.00filing
2026-09-092026-09-090Phillips Anne M.DirectorDisposition to issuer34,328$0.00filing
2026-09-092026-09-090Phillips Anne M.DirectorDisposition to issuer19,516$0.00filing
2026-09-092026-09-090Scheeren JosephDirectorDisposition to issuer34,328$0.00filing
2026-09-092026-09-090Scheeren JosephDirectorDisposition to issuer19,516$0.00filing
2026-09-092026-09-090Wright RobinDirectorDisposition to issuer20,394$0.00filing
2026-09-092026-09-090Hammacher AlexDirectorDisposition to issuer19,516$0.00filing
2026-09-092026-09-090Hooftman LeonChief Medical OfficerDisposition to issuer361,530filing
2026-09-092026-09-090Morgon Pierre A.DirectorDisposition to issuer10,506filing
2026-09-092026-09-090Morgon Pierre A.DirectorDisposition to issuer18,604$0.00filing
2026-09-092026-09-090Morgon Pierre A.DirectorDisposition to issuer20,174$0.00filing
2026-09-092026-09-090Phillips Anne M.DirectorDisposition to issuer18,604$0.00filing
2026-09-092026-09-090Phillips Anne M.DirectorDisposition to issuer20,174$0.00filing
2026-09-092026-09-090Scheeren JosephDirectorDisposition to issuer18,604$0.00filing
2026-09-092026-09-090Scheeren JosephDirectorDisposition to issuer20,174$0.00filing
2026-09-092026-09-090Wright RobinDirectorDisposition to issuer34,328$0.00filing
2026-09-092026-09-090Wright RobinDirectorDisposition to issuer19,516$0.00filing
2026-09-092026-09-090Phillips Anne M.DirectorDisposition to issuer19,197$0.00filing
2026-09-092026-09-090Scheeren JosephDirectorDisposition to issuer23,000filing
2026-09-092026-09-090Scheeren JosephDirectorDisposition to issuer19,197$0.00filing
2026-09-092026-09-090Wright RobinDirectorDisposition to issuer48,256filing
2026-09-092026-09-090Wright RobinDirectorDisposition to issuer18,604$0.00filing
2026-09-092026-09-090Wright RobinDirectorDisposition to issuer20,174$0.00filing
2026-09-092026-09-090Wright RobinDirectorDisposition to issuer19,197$0.00filing

Source: U.S. Securities and Exchange Commission, EDGAR

Barinthus Biotherapeutics plc. insider transactions — 49 filings on record — Tapewire